Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
CARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), […]
Churchill Resources to Present at the Emerging Growth Conference January 11, 2024
TORONTO, Jan. 08, 2024 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce […]
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose (RP2D) expected in Q2 […]
Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity
Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis (MG) […]
Solid Biosciences Announces $109 Million Private Placement
CHARLESTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic […]
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2023
BRADENTON, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), […]
BurgerFi Provides Fiscal Year 2023 Business Update
Sets Initial Business Outlook for Fiscal Year 2024 Focused on Five Key Strategic Initiatives FORT LAUDERDALE, Fla., Jan. 08, 2024 […]
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
Preliminary unaudited revenue expected to be between $17.5 million and $18.0 million for Q4 2023 and between $64.9 million and […]
Fortrea Previews J.P. Morgan Healthcare Conference Updates
DURHAM, N.C., Jan. 08, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today previewed […]
Relay Therapeutics Announces $30 Million Private Placement Financing
CAMBRIDGE, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
